The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103817151 10381715 1 I 20140723 20140813 20140813 PER US-009507513-1407USA011147 MERCK 0.00 Y 0.00000 20140813 N CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103817151 10381715 1 PS EMEND APREPITANT 1 INTRAVENOUS DOSE: 150 MG, ONCE D 22023 150 MG INJECTION 1X

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103817151 10381715 1 Prophylaxis of nausea and vomiting

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
103817151 10381715 Discomfort
103817151 10381715 Dyspnoea
103817151 10381715 Feeling abnormal
103817151 10381715 Hyperhidrosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found